Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples